Matching articles for "neffy"
Drugs Past Their Expiration Date
The Medical Letter on Drugs and Therapeutics • January 5, 2026; (Issue 1745)
Healthcare providers are often asked if drugs can
be used past their expiration date. Because of legal
restrictions and liability concerns, manufacturers do
not sanction such use and usually do not...
Healthcare providers are often asked if drugs can
be used past their expiration date. Because of legal
restrictions and liability concerns, manufacturers do
not sanction such use and usually do not comment
on the safety or effectiveness of their products beyond the date on the label. Since our last article on this
subject, more data have become available.
In Brief: Epinephrine 1 mg Nasal Spray (neffy)
The Medical Letter on Drugs and Therapeutics • April 28, 2025; (Issue 1727)
The FDA has approved a 1-mg epinephrine nasal spray
(neffy - ARS Pharma) for emergency treatment of
type 1 hypersensitivity reactions including anaphylaxis
in patients ≥4 years old who weigh 15 to...
The FDA has approved a 1-mg epinephrine nasal spray
(neffy - ARS Pharma) for emergency treatment of
type 1 hypersensitivity reactions including anaphylaxis
in patients ≥4 years old who weigh 15 to <30 kg. A
2-mg formulation of neffy was approved in 2024 for
use in patients who weigh ≥30 kg.
An Epinephrine Nasal Spray (neffy) for Anaphylaxis
The Medical Letter on Drugs and Therapeutics • October 14, 2024; (Issue 1713)
The FDA has approved an epinephrine nasal spray
(neffy – ARS Pharma) for emergency treatment
of type 1 hypersensitivity reactions including
anaphylaxis in patients who weigh ≥30 kg. It is
the first...
The FDA has approved an epinephrine nasal spray
(neffy – ARS Pharma) for emergency treatment
of type 1 hypersensitivity reactions including
anaphylaxis in patients who weigh ≥30 kg. It is
the first noninjectable epinephrine product to be
approved for this indication.